Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition-Reference-Cited by-同舟云学术

Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition

Published:2012-06 Issue:2 Volume:319 Page:232-241
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Kimbung Siker,Biskup Ewa,Johansson Ida,Aaltonen Kristina,Ottosson-Wadlund Astrid,Gruvberger-Saal Sofia,Cunliffe Heather,Fadeel Bengt,Loman Niklas,Berglund Pontus,Hedenfalk Ingrid

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc. Natl Acad. Sci. USA,2003

2. Gene-expression profiles in hereditary breast cancer;Hedenfalk;N. Engl. J. Med.,2001

3. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer;Teschendorff;Genome Biol.,2007

4. The PARP superfamily;Ame;BioEssays,2004

5. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective;Sandhu;Eur. J. Cancer,2010

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prioritization of bioactive compounds envisaging yohimbine as a multi targeted anticancer agent: insight from molecular docking and molecular dynamics simulation;Journal of Biomolecular Structure and Dynamics;2022-12-19

2. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer;Mutation Research/Reviews in Mutation Research;2021-01

3. Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family;Journal of Assisted Reproduction and Genetics;2020-04-30

4. Increasing radiosensitivity by the combined inhibition of PARP1 and PI3K in BRCA1-mutated triple negative breast cancer;INT J RADIAT RES;2020

5. Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets;Pathology - Research and Practice;2020-04